Monday, November 28, 2016 7:55:30 PM
My guess is the market wanted more up front cash and/or the market is weak in this segment until a later stage. The current phase status IMO is very good for continued success in this product. Guess we will have to wait some more. In the mean time buying the channel bottom and selling weakness continues to add green to ones' account. Cash up front is a big deal in the bios. Would like to have seen $30-50million on the front end, but I don't think this is the best they have in the pipeline.
Seel can weigh in with better insight on that.
I still trust Baker Bro. Their deals most often take time, however their win percentage is excellent.
They also weren't averse to doubling down on a .10center last Q. Up to 8.5million shares now.
IMO worth looking at the number of under $5 stocks in their Baker Bros Advisors LLC portfolio to get some additional ideas.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM